Log in to save to my catalogue

APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11775459

APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

About this item

Full title

APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

Publisher

United States: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2025-01, Vol.21 (1), p.e14392-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley and Sons Inc

More information

Scope and Contents

Contents

INTRODUCTION
While the role of apolipoprotein E (APOE) ε4 in Alzheimer's disease (AD) susceptibility has been studied extensively, much less is known about the differences in disease presentation in APOE ε4 carriers versus non‐carriers.
METHODS
To help elucidate these differences, we performed a broad analysis comparing the regional levels...

Alternative Titles

Full title

APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11775459

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11775459

Other Identifiers

ISSN

1552-5260,1552-5279

E-ISSN

1552-5279

DOI

10.1002/alz.14392

How to access this item